Thomas H. Keller
10 Biopolis Road
Chromos, 138670, Singapore
Chromos, 138670, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Structural model of human PORCN illuminates disease-associated variants and drug-binding sites.
Journal: Journal of cell science
Published: September 16, 2021
Structure-activity relationship studies of allosteric inhibitors of EYA2 tyrosine phosphatase.
Journal: Protein science : a publication of the Protein Society
Published: August 23, 2021
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: July 16, 2021
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*.
Journal: Angewandte Chemie (International ed. in English)
Published: April 20, 2021
Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe.
Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe.
Journal: The Journal of experimental medicine
Published: December 14, 2020
Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.
Journal: Journal of medicinal chemistry
Published: January 08, 2020
Probing biological mechanisms with chemical tools.
Journal: Pharmacological research
Published: October 16, 2019
Correction to "Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3".
Journal: ACS medicinal chemistry letters
Published: August 16, 2019
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3.
Journal: ACS medicinal chemistry letters
Published: April 15, 2019
Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues.
Journal: ACS medicinal chemistry letters
Published: November 12, 2018
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.
Journal: Molecular cancer therapeutics
Published: November 01, 2018
Last Updated: 09/26/2026